First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, As a Single Agent in Patients with Advanced Solid Tumors
The Oncologist(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined